Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer.

MLA

Marcion, Guillaume, et al. “Nanofitins Targeting Heat Shock Protein 110: An Innovative Immunotherapeutic Modality in Cancer.” International Journal of Cancer, vol. 148, no. 12, June 2021, pp. 3019–31. EBSCOhost, https://doi.org/10.1002/ijc.33485.

APA

Marcion, G., Hermetet, F., Neiers, F., Uyanik, B., Dondaine, L., Dias, A. M. M., Da Costa, L., Moreau, M., Bellaye, P.-S., Collin, B., Gobbo, J., Briand, L., Seigneuric, R., Kitten, O., Cinier, M., & Garrido, C. (2021). Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer. International Journal of Cancer, 148(12), 3019–3031. https://doi.org/10.1002/ijc.33485

Chicago

Marcion, Guillaume, François Hermetet, Fabrice Neiers, Burhan Uyanik, Lucile Dondaine, Alexandre M M Dias, Laurène Da Costa, et al. 2021. “Nanofitins Targeting Heat Shock Protein 110: An Innovative Immunotherapeutic Modality in Cancer.” International Journal of Cancer 148 (12): 3019–31. doi:10.1002/ijc.33485.